Revenue and EBITDA are the sponsor’s targets; depreciation, interest, tax and net profit are independently re-derived. Unlike a perennial-crop business there is no biological J-curve: the manufacturing and processing plant depreciates on a straight-line basis from the point each vintage commissions, so depreciation builds steadily as the asset base is completed.
|
Year 1 |
Year 2 |
Year 3 |
Year 4 |
Year 5 |
|
|---|---|---|---|---|---|
|
Revenue |
850 |
1,600 |
2,900 |
4,400 |
6,200 |
|
EBITDA |
95 |
210 |
420 |
710 |
1,050 |
|
EBITDA margin |
11.2% |
13.1% |
14.5% |
16.1% |
16.9% |
|
Less: depreciation |
-40 |
-91 |
-132 |
-144 |
-153 |
|
EBIT |
55 |
119 |
288 |
566 |
897 |
|
Less: net interest |
-32 |
-83 |
-104 |
-97 |
-69 |
|
Profit before tax |
23 |
36 |
184 |
470 |
828 |
|
Less: taxation (27%) |
-6 |
-10 |
-50 |
-127 |
-224 |
|
Net profit after tax |
17 |
26 |
134 |
343 |
604 |
|
Net margin |
2.0% |
1.6% |
4.6% |
7.8% |
9.7% |
|
Memo: sponsor NPAT |
38 |
92 |
210 |
390 |
620 |
|
Variance to sponsor |
-21 |
-66 |
-76 |
-47 |
-16 |
Analyst flagThe re-derived profits sit below the sponsor’s in every year
Once full depreciation on the plant base, cash interest on the R1,020m of debt, and 27% tax are loaded, the independently re-derived net profit runs below the sponsor’s stated figures, a variance of about –R21m in Year 1, widening to –R76m in Year 3 as the debt peaks, then narrowing to roughly –R16m by Year 5. The gap reflects a fuller below-EBITDA treatment than the sponsor’s, not a weaker business: the plan is profitable in every year and the variance converges as the debt amortises. We disclose it rather than adopt the sponsor’s more optimistic below-EBITDA view.
The capacity ramp underlies the revenue trajectory
There is no biological maturation curve in this business; the revenue trajectory is driven instead by the commissioning of plant capacity and the filling of it. Throughput climbs from roughly 120,000 tonnes in Year 1 to about 890,000 tonnes by Year 5, utilisation builds from around 40% to 84%, and, crucially, the blended margin expands as the product mix shifts from thin-margin bulk trading toward milled, branded and processed products. Revenue compounds off a genuine Year-1 base rather than from zero, because the trading and early processing streams generate meaningful volume from the outset.
The margin story is the one to watch. EBITDA margin expands from about 11% to 17% not because commodity prices rise, they are largely passed through, but because milling, blending, coating, packaging and branding progressively displace raw trading in the revenue mix. Re-derived net profit grows from R17m to about R604m by Year 5 as volume scales, the margin lifts and the debt amortises.
Working capital and commodity seasonality
Commodity earnings are working-capital-intensive in a way that must be modelled explicitly. Grain and pulse are procured through the harvest window, cleaned, processed and stored, and revenue, receivables and inventory swell before customer payment unwinds them. Because the Group processes a diversified basket across multiple crops and seasons, and because milled and branded products release year-round, the intra-year cycle is smoother than a single-crop fresh-produce business, but inventory and receivables are still substantial, which is why net working capital is set at about 10% of revenue (net of payables and supplier finance) and a seasonal revolver sits alongside the term debt.
NoteWorking capital is a funding line, not an afterthought
In a commodity-processing and trading business the single most common cause of distress is not unprofitability but a working-capital squeeze, cash tied up in inventory and receivables when prices move or a shipment is delayed. The plan ring-fences R110m of the raise for working capital and assumes a committed seasonal revolver on top. Sizing and committing that facility to the peak inventory-and-receivables build, and managing inventory and hedging with discipline, is as important to survival as it is to returns.